Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-83,793
Closed -$1.48M 4891
2025
Q4
$1.48M Buy
83,793
+57,025
+213% +$1.34M ﹤0.01% 1492
2025
Q3
$907K Buy
26,768
+5,063
+23% +$174K ﹤0.01% 1575
2025
Q2
$759K Buy
+21,705
New +$714K ﹤0.01% 1400
2024
Q2
Sell
-28,216
Closed -$452K 3248
2024
Q1
$452K Sell
28,216
-938
-3% -$19.8K ﹤0.01% 1323
2023
Q4
$796K Sell
29,154
-60,769
-68% -$1.6M 0.01% 1096
2023
Q3
$2.19M Buy
+89,923
New +$2.39M 0.02% 582
2021
Q4
Sell
-9,726
Closed -$1.02M 4221
2021
Q3
$1.02M Buy
9,726
+3,130
+47% +$449K 0.01% 1249
2021
Q2
$1.17M Buy
+6,596
New +$1.06M 0.01% 922

Other funds holding ZLAB

HRT Financial's ZLAB Position: Q1 2026 in Review

HRT Financial sold out of Zai Lab (ZLAB) in Q1 2026, closing a stake of 83,793 shares — an estimated $1.48M sold.

HRT Financial first reported a position in ZLAB in Q2 2021 and held it in 8 quarters. The position peaked at $2.19M in Q3 2023. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • HRT Financial reported no remaining Zai Lab position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 83,793 Zai Lab shares in Q1 2026, an estimated $1.48M.
  • HRT Financial first reported a position in Zai Lab in Q2 2021 and held it in 8 quarters.
  • HRT Financial's Zai Lab position peaked at $2.19M in Q3 2023.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.